Combination Pills for Treatment of High Blood Pressure: Cost-effectiveness in The Asia Pacific Region

Heart Lung Circ. 2017 Apr;26(4):313-315. doi: 10.1016/j.hlc.2017.02.001.

Authors

Emily R Atkins¹, Thomas Lung², Julie Redfern²

Affiliations

¹ The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: eatkins@georgeinstitute.org.au.
² The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

PMID: 28241926
DOI: 10.1016/j.hlc.2017.02.001

No abstract available

Publication types

Editorial

MeSH terms

Blood Pressure / drug effects*
Cost-Benefit Analysis
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Hypertension* / drug therapy
Hypertension* / epidemiology
Hypertension* / physiopathology
Hypoglycemic Agents / administration & dosage*
New South Wales / epidemiology

Substances

Hypoglycemic Agents